[go: up one dir, main page]

DK569687D0 - IFOSPHAMIDE LYPHILIZATE AND PROCEDURE FOR ITS PREPARATION - Google Patents

IFOSPHAMIDE LYPHILIZATE AND PROCEDURE FOR ITS PREPARATION

Info

Publication number
DK569687D0
DK569687D0 DK569687A DK569687A DK569687D0 DK 569687 D0 DK569687 D0 DK 569687D0 DK 569687 A DK569687 A DK 569687A DK 569687 A DK569687 A DK 569687A DK 569687 D0 DK569687 D0 DK 569687D0
Authority
DK
Denmark
Prior art keywords
lyphilizate
ifosphamide
procedure
preparation
ifosfamide
Prior art date
Application number
DK569687A
Other languages
Danish (da)
Other versions
DK569687A (en
DK169308B1 (en
Inventor
Dieter Sauerbier
Uwe-Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of DK569687D0 publication Critical patent/DK569687D0/en
Publication of DK569687A publication Critical patent/DK569687A/en
Application granted granted Critical
Publication of DK169308B1 publication Critical patent/DK169308B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Amplifiers (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1. A lyophilized preparation consisting of ifosfamide and 0.1 to 17 parts by weight hexitol per part by weight ifosfamide and, optionally, other standard pharmaceutical auxiliaries.
DK569687A 1986-10-31 1987-10-30 Lyophilized preparation, process for preparing an ifosfamide lyophilizate preparation and the ifosfamide lyophilizate preparation obtained by the method DK169308B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31
DE3637089 1986-10-31

Publications (3)

Publication Number Publication Date
DK569687D0 true DK569687D0 (en) 1987-10-30
DK569687A DK569687A (en) 1988-05-01
DK169308B1 DK169308B1 (en) 1994-10-10

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569687A DK169308B1 (en) 1986-10-31 1987-10-30 Lyophilized preparation, process for preparing an ifosfamide lyophilizate preparation and the ifosfamide lyophilizate preparation obtained by the method

Country Status (25)

Country Link
EP (1) EP0265812B1 (en)
JP (1) JPS63159319A (en)
KR (1) KR900003491B1 (en)
AT (1) ATE55250T1 (en)
AU (1) AU598602B2 (en)
CA (1) CA1314231C (en)
DD (1) DD262582A5 (en)
DE (1) DE3764235D1 (en)
DK (1) DK169308B1 (en)
EG (1) EG18333A (en)
ES (1) ES2017982B3 (en)
FI (1) FI87140C (en)
GE (1) GEP19971025B (en)
GR (1) GR3000708T3 (en)
HU (1) HU197987B (en)
IL (1) IL84312A (en)
IN (1) IN168119B (en)
LV (1) LV10051B (en)
MX (1) MX8958A (en)
NO (1) NO873860L (en)
PT (1) PT86032B (en)
RU (1) RU1836079C (en)
UA (1) UA11075A (en)
YU (1) YU197387A (en)
ZA (1) ZA878183B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334083B1 (en) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamide-mesna-lyophilized composition and process to prepare it
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (en) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamide lyophilizate preparations
CN1299277A (en) * 1998-03-03 2001-06-13 盐野义制药株式会社 Pharmaceutical compositions contg. the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy] acetate
US20050272698A1 (en) * 2002-09-05 2005-12-08 Daftary Gautam V Liquid stable composition of oxazaphosphorine with mesna
NZ540484A (en) * 2002-12-02 2008-03-28 Bharat Serums & Vaccines Ltd Stable, clear, aqueous ifosfamide compositions for parenteral administration and a process for their preparation
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
WO2008038126A2 (en) * 2006-09-29 2008-04-03 Infa S.A. Packaging system for pharmaceutical compositions and kit for intravenous administration
CN105900385B (en) * 2014-12-04 2019-08-27 华为技术有限公司 Load Distribution in Data Communication Networks

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (en) * 1977-05-09 1978-11-16 Walton J Smith Anhydrous compsn. prodn. by freeze drying hydrated, hydrolysable prod. - esp. aspirin or aspirin salt solns.
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
LV10051B (en) 1995-06-20
KR880004814A (en) 1988-06-27
GEP19971025B (en) 1997-04-06
DE3764235D1 (en) 1990-09-13
FI874727L (en) 1988-05-01
ZA878183B (en) 1988-05-02
EG18333A (en) 1993-12-30
YU197387A (en) 1988-12-31
DK569687A (en) 1988-05-01
UA11075A (en) 1996-12-25
ATE55250T1 (en) 1990-08-15
MX8958A (en) 1993-12-01
IL84312A0 (en) 1988-03-31
IL84312A (en) 1991-11-21
EP0265812A1 (en) 1988-05-04
RU1836079C (en) 1993-08-23
FI874727A0 (en) 1987-10-27
AU598602B2 (en) 1990-06-28
DD262582A5 (en) 1988-12-07
FI87140C (en) 1992-12-10
FI87140B (en) 1992-08-31
IN168119B (en) 1991-02-09
NO873860D0 (en) 1987-09-15
NO873860L (en) 1988-05-02
KR900003491B1 (en) 1990-05-21
GR3000708T3 (en) 1991-10-10
ES2017982B3 (en) 1991-03-16
HUT44932A (en) 1988-05-30
JPS63159319A (en) 1988-07-02
HU197987B (en) 1989-07-28
AU8052987A (en) 1988-05-05
JPH0543684B2 (en) 1993-07-02
LV10051A (en) 1994-05-10
PT86032A (en) 1987-11-01
PT86032B (en) 1990-08-31
CA1314231C (en) 1993-03-09
EP0265812B1 (en) 1990-08-08
DK169308B1 (en) 1994-10-10

Similar Documents

Publication Publication Date Title
NO900528L (en) ANTHELMINTICS, PROCEDURE FOR PREPARING THEREOF, AND PREPARATION WITH A CONTENT THEREOF.
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
PT90030A (en) PROCESS FOR THE PREPARATION OF IFOSPHAMIDE AND MESNA LYOPHYLISATE
FI872460A7 (en) Method for the preparation of L-tert-leucine and L-phosphinothricine by transamination.
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
ES557152A0 (en) A PROCEDURE FOR PREPARING LAUDANS
DK569687A (en) IFOSPHAMIDE LYPHILIZATE AND PROCEDURE FOR ITS PREPARATION
NO880473L (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES AND THEIR USE AS A MEDICINE.
NO881308D0 (en) DIHYDROPYRIDINAMIDES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICALS.
DK103987D0 (en) SUBSTITUTED 1,3,4,9-TETRAHYDROPYRANOE3,4-BAAINDOL-L-ACETIC ACIDS, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
NO871481L (en) SUBSTITUTED THIACYCLOALKENO (3,2-B) PYRIDINES AND PROCEDURES FOR THEIR PREPARATION.
NZ219623A (en) N-(heterocyclic-substituted phenyl)-n'-benzoylurea derivatives and pesticidal compositions
DK284588A (en) BETA-LACTAM COMPOUNDS, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS.
ES2019100B3 (en) TRICHLOROPHENOL PREPARATION.
DK164906C (en) ISOTHIOUR INGREDIENT DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
DK574588A (en) PHARMACEUTICALS FOR HUMAN AND ANIMALS WITH ANTIVIRAL AND ANTITUMORAL EFFECTS AND PROCEDURES FOR PRODUCING THEREOF
NO880639D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXIMETERS OF 2,6-DIOKSABICYCLO (3, 3, 0) OCTANONS.
NO164539C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-NAFTHYL-2,4-DIMETHYL-3H-1,2,4-TRIAZOL-3-THION.
IT1173551B (en) DERIVATIVE OF P-AMINOPHENOL WITH MUCOSECRETOLYTIC-FLUIDIFYING AND ANTIPYRETIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS
NO912745D0 (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,2,5,6-TETRAHYDROPYRIDE COMPOUNDS.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired